Aspen Aerogels, Inc. (NYSE:ASPN – Get Free Report) major shareholder Wood River Capital, Llc sold 12,280,426 shares of the business’s stock in a transaction dated Wednesday, September 23rd. The stock was sold at an average price of $4.73, for a total value of $58,086,414.98. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.
Aspen Aerogels Stock Down 6.8%
Shares of ASPN stock traded down $0.39 during trading hours on Thursday, reaching $5.29. 2,364,746 shares of the stock were exchanged, compared to its average volume of 683,511. The business’s fifty day moving average is $5.19 and its two-hundred day moving average is $4.87. The firm has a market capitalization of $439.18 million, a P/E ratio of -3.46 and a beta of 2.97. Aspen Aerogels, Inc. has a 12-month low of $2.30 and a 12-month high of $9.35. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.52 and a quick ratio of 2.24.
Aspen Aerogels (NYSE:ASPN – Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The construction company reported ($0.22) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.01. Aspen Aerogels had a negative net margin of 62.45% and a negative return on equity of 31.12%. The company had revenue of $49.85 million during the quarter, compared to the consensus estimate of $42.42 million. Aspen Aerogels has set its Q3 2026 guidance at -0.110–0.070 EPS. As a group, research analysts expect that Aspen Aerogels, Inc. will post -0.69 EPS for the current fiscal year.
Institutional Inflows and Outflows
Analyst Ratings Changes
ASPN has been the subject of a number of analyst reports. Roth Capital reiterated a “buy” rating and set a $7.75 target price on shares of Aspen Aerogels in a research note on Friday, August 7th. B. Riley Financial restated a “buy” rating on shares of Aspen Aerogels in a research note on Friday, August 7th. Barclays lifted their price target on Aspen Aerogels from $4.00 to $5.00 and gave the stock an “underweight” rating in a report on Tuesday, August 11th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Aspen Aerogels in a report on Monday. Finally, Wall Street Zen lowered Aspen Aerogels from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. Four research analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $5.94.
Get Our Latest Stock Analysis on ASPN
Aspen Aerogels Company Profile
Aspen Aerogels, Inc is a technology company that develops, manufactures and sells advanced aerogel-based materials. Aerogels are highly porous materials designed to provide thermal insulation, fire protection and other performance benefits in applications where conventional insulation may be less effective or require more space.
The company serves the energy, industrial and automotive markets. Its products include thermal barriers for electric vehicle batteries, insulation materials for industrial and energy infrastructure, and specialty aerogel products used in applications involving heat management, fire mitigation and cryogenic or high-temperature environments.
Featured Stories
- Five stocks we like better than Aspen Aerogels
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
- Paychex Plunges, Providing the Entry Investors Have Been Waiting For
- The Case for Buying High-Yield General Mills Just Strengthened
- SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.
